These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29278442)

  • 1. Sevelamer hydrochloride suppresses proliferation of parathyroid cells during the early phase of chronic renal failure in rats.
    Xiao X; Liu Y; Zhong X; Liu Y; Zhou D; Xiong X; Ran J
    Nephrology (Carlton); 2019 Jan; 24(1):127-133. PubMed ID: 29278442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sevelamer hydrochloride (Renagel), a non-calcaemic phosphate binder, arrests parathyroid gland hyperplasia in rats with progressive chronic renal insufficiency.
    Nagano N; Miyata S; Obana S; Ozai M; Kobayashi N; Fukushima N; Burke SK; Wada M
    Nephrol Dial Transplant; 2001 Sep; 16(9):1870-8. PubMed ID: 11522872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sevelamer hydrochloride, a calcium-free phosphate binder, inhibits parathyroid cell proliferation in partially nephrectomized rats.
    Nagano N; Miyata S; Obana S; Kobayashi N; Abe M; Fukushima N; Wada M
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii81-5. PubMed ID: 12771309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sevelamer hydrochloride reverses parathyroid gland enlargement via regression of cell hypertrophy but not apoptosis in rats with chronic renal insufficiency.
    Nagano N; Miyata S; Abe M; Wakita S; Kobayashi N; Wada M
    Nephrol Dial Transplant; 2006 Mar; 21(3):634-43. PubMed ID: 16169864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats.
    Cozzolino M; Dusso AS; Liapis H; Finch J; Lu Y; Burke SK; Slatopolsky E
    J Am Soc Nephrol; 2002 Sep; 13(9):2299-308. PubMed ID: 12191974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.
    Cozzolino M; Staniforth ME; Liapis H; Finch J; Burke SK; Dusso AS; Slatopolsky E
    Kidney Int; 2003 Nov; 64(5):1653-61. PubMed ID: 14531797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease].
    Nagano N; Miyata S; Abe M; Wakita S; Kobayashi N; Wada M
    Clin Calcium; 2005 Sep; 15 Suppl 1():35-9; discussion 39-40. PubMed ID: 16272627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sevelamer hydrochloride, a phosphate binder, protects against deterioration of renal function in rats with progressive chronic renal insufficiency.
    Nagano N; Miyata S; Obana S; Kobayashi N; Fukushima N; Burke SK; Wada M
    Nephrol Dial Transplant; 2003 Oct; 18(10):2014-23. PubMed ID: 13679475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats.
    Nagano N; Miyata S; Abe M; Kobayashi N; Wakita S; Yamashita T; Wada M
    Kidney Int; 2006 Feb; 69(3):531-7. PubMed ID: 16395276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats.
    Katsumata K; Kusano K; Hirata M; Tsunemi K; Nagano N; Burke SK; Fukushima N
    Kidney Int; 2003 Aug; 64(2):441-50. PubMed ID: 12846739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats: possible direct role of phosphorus.
    Yi H; Fukagawa M; Yamato H; Kumagai M; Watanabe T; Kurokawa K
    Nephron; 1995; 70(2):242-8. PubMed ID: 7566311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative activity of the parathyroid cells in rats with secondary hyperparathyroidism.
    Yamaguchi S; Yachiku S; Hashimoto H; Okuyama M; Tsurukawa H; Kawakami N; Watabe Y; Sue Y
    Virchows Arch; 2001 Apr; 438(4):388-93. PubMed ID: 11355174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of skeletal resistance to parathyroid hormone in the rat: effect of renal failure and dietary phosphorus.
    Bover J; Jara A; Trinidad P; Rodriguez M; Felsenfeld AJ
    Bone; 1999 Sep; 25(3):279-85. PubMed ID: 10495131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD.
    Miller G; Davis J; Shatzen E; Colloton M; Martin D; Henley CM
    Nephrol Dial Transplant; 2012 Jun; 27(6):2198-205. PubMed ID: 22036941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure.
    Zanella MT; Silva MC; Peres RB; Ferreira SR; Draibe SA; Vieira JG
    Braz J Med Biol Res; 1990; 23(3-4):235-43. PubMed ID: 2094538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-κB activation contributes to parathyroid cell proliferation in chronic kidney disease.
    Kan S; Zhang W; Mao J; Wang M; Ni L; Zhang M; Zhang Q; Chen J
    J Nephrol; 2018 Dec; 31(6):941-951. PubMed ID: 30171599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels.
    Terai K; Nara H; Takakura K; Mizukami K; Sanagi M; Fukushima S; Fujimori A; Itoh H; Okada M
    Br J Pharmacol; 2009 Apr; 156(8):1267-78. PubMed ID: 19302594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of FGF-23-mediated ERK/MAPK signaling pathway on parathyroid hormone secretion of parathyroid cells in rats with secondary hyperparathyroidism.
    Chen XJ; Chen X; Wu WJ; Zhou Q; Gong XH; Shi BM
    J Cell Physiol; 2018 Sep; 233(9):7092-7102. PubMed ID: 29633272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PA21, a novel phosphate binder, improves renal osteodystrophy in rats with chronic renal failure.
    Yaguchi A; Tatemichi S; Takeda H; Kobayashi M
    PLoS One; 2017; 12(7):e0180430. PubMed ID: 28704404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis.
    Takei T; Otsubo S; Uchida K; Matsugami K; Mimuro T; Kabaya T; Akiba T; Nitta K
    Nephron Clin Pract; 2008; 108(4):c278-83. PubMed ID: 18434749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.